HealthCare Global Enterprises Limited’s board approved a rights issue of fully paid-up equity shares to raise up to ₹425 crore from eligible shareholders. The Rights Issue Committee will determine the issue price, entitlement ratio, record date, and other terms.

HealthCare Global Enterprises board approves ₹425

HealthCare Global Enterprises Approves ₹425-Crore Rights Issue

The board of directors of HealthCare Global Enterprises Ltd has approved the issuance of fully paid-up equity shares through a rights issue to eligible shareholders.

Key Highlights:

Total amount to be raised: ₹425 crore
Rights issue to be offered to equity shareholders as on a record date to be determined and notified by the company
Specific terms, including issue price, rights entitlement ratio, record date, timing of the rights issue, and terms of payment, to be decided by the board or the Rights Issue Committee

Last year in September, Aceso Company part of the CVC Network, sold nearly a 6% stake in HealthCare Global Enterprises (HCG) via a block deal on the NSE, raising ₹552 crore at an average price of ₹695 per share.

Main Shareholders:

Tata Asset Management: 4.1%
Motilal Oswal AMC: 2.8%
Nippon India Mutual Fund: 2.5%
Other domestic fund holders: 1.2%
Foreign portfolio investors: 2.2%

HealthCare Global Enterprises operates cancer treatment clinics, multispeciality hospitals, and fertility treatment centres.

Recent Stock Performance:

Shares of Healthcare Global Enterprises Ltd ended at ₹578.60, down by ₹5.80, or 0.99%, on the BSE today, February 17.

Also Read:

HCG eyes 20% margin in FY26 amid outpatient shift, strong urban growth
Insurer–hospital row hurt sentiment, not patient footfall, says InCred’s Aditya Khemka